There was also a growing body of evidence suggesting that elevated levels of pro-inflammatory markers, including TNF-α, IL-6, and CRP, play a vital role in the pathogenesis of T2DM (Liaqat et al., 2021; Hyun et al., 2013). The gene discussed is IL6; the disease is type 2 diabetes mellitus.